Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Global health and food supply are endangered by an increasing frequency of antifungal resistance in pathogenic fungi. Wild-type fission yeast, Schizosaccharomyces pombe, can gain resistance to insults such as caffeine and antifungal compounds through reversible epimutations. Resistant epimutants exhibit histone H3K9 methylation-dependent heterochromatin islands at various chromosomal locations, reducing expression of underlying genes. Two genes whose heterochromatin island-induced repression causes resistance encode mitochondrial proteins: the LYR domain protein Cup1 and the Cox1 translation regulator Ppr4. Genetic mutations, cup1-tt and ppr4Delta, that phenocopy their respective epimutants, cause mitochondrial dysfunction, including respiratory deficiency, poor growth on non-glucose carbon sources, and elevated reactive oxygen species. RNA-Seq analyses indicate that cup1-tt and ppr4Delta cells activate the mitonuclear retrograde pathway and the Pap1 transcription factor-dependent oxidative stress response pathways. Both mutants show increased nuclear localisation of Pap1 and its recruitment to promoters of genes encoding oxidoreductases and membrane transporters, causing increased efflux activity. cup1 and ppr4 epimutants also show mitochondrial dysfunction phenotypes and increased efflux, explaining how heterochromatin-island epimutations cause drug resistance. Thus, wild-type cells harness epimutations that impose mitochondrial dysfunction to bypass external insults. As mitochondrial dysfunction has been linked to antifungal resistance in several fungi, similar epimutations likely contribute to development of resistance in fungal pathogens.
Global health and food supply are endangered by an increasing frequency of antifungal resistance in pathogenic fungi. Wild-type fission yeast, Schizosaccharomyces pombe, can gain resistance to insults such as caffeine and antifungal compounds through reversible epimutations. Resistant epimutants exhibit histone H3K9 methylation-dependent heterochromatin islands at various chromosomal locations, reducing expression of underlying genes. Two genes whose heterochromatin island-induced repression causes resistance encode mitochondrial proteins: the LYR domain protein Cup1 and the Cox1 translation regulator Ppr4. Genetic mutations, cup1-tt and ppr4Delta, that phenocopy their respective epimutants, cause mitochondrial dysfunction, including respiratory deficiency, poor growth on non-glucose carbon sources, and elevated reactive oxygen species. RNA-Seq analyses indicate that cup1-tt and ppr4Delta cells activate the mitonuclear retrograde pathway and the Pap1 transcription factor-dependent oxidative stress response pathways. Both mutants show increased nuclear localisation of Pap1 and its recruitment to promoters of genes encoding oxidoreductases and membrane transporters, causing increased efflux activity. cup1 and ppr4 epimutants also show mitochondrial dysfunction phenotypes and increased efflux, explaining how heterochromatin-island epimutations cause drug resistance. Thus, wild-type cells harness epimutations that impose mitochondrial dysfunction to bypass external insults. As mitochondrial dysfunction has been linked to antifungal resistance in several fungi, similar epimutations likely contribute to development of resistance in fungal pathogens.
Antimicrobial resistance (AMR), frequently considered a major global public health threat, requires a comprehensive understanding of its emergence, mechanisms, advances, and implications. AMR’s epidemiological landscape is characterized by its widespread prevalence and constantly evolving patterns, with multidrug-resistant organisms (MDROs) creating new challenges every day. The most common mechanisms underlying AMR (i.e., genetic mutations, horizontal gene transfer, and selective pressure) contribute to the emergence and dissemination of new resistant strains. Therefore, mitigation strategies (e.g., antibiotic stewardship programs—ASPs—and infection prevention and control strategies—IPCs) emphasize the importance of responsible antimicrobial use and surveillance. A One Health approach (i.e., the interconnectedness of human, animal, and environmental health) highlights the necessity for interdisciplinary collaboration and holistic strategies in combating AMR. Advancements in novel therapeutics (e.g., alternative antimicrobial agents and vaccines) offer promising avenues in addressing AMR challenges. Policy interventions at the international and national levels also promote ASPs aiming to regulate antimicrobial use. Despite all of the observed progress, AMR remains a pressing concern, demanding sustained efforts to address emerging threats and promote antimicrobial sustainability. Future research must prioritize innovative approaches and address the complex socioecological dynamics underlying AMR. This manuscript is a comprehensive resource for researchers, policymakers, and healthcare professionals seeking to navigate the complex AMR landscape and develop effective strategies for its mitigation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.